ID

42560

Beschrijving

Maintaining Bone Strength in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00391950

Link

https://clinicaltrials.gov/show/NCT00391950

Trefwoorden

Versies (2)
  1. 08-06-17 08-06-17 -
  2. 02-09-21 02-09-21 -
Geüploaded op

2 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Prostate Cancer NCT00391950

Engels

Eligibility Prostate Cancer NCT00391950

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed diagnosis of carcinoma of the prostate
Beschrijving

Prostate carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0600139
no distant metastases
Beschrijving

Distant metastasis Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C1269798
UMLS CUI [1,2]
C0332197
patients must be candidates for androgen deprivation therapy (adt)
Beschrijving

Indication Antiandrogen therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0279492
patient with a baseline bmd t-score at or below -1 standard deviations in the lumbar spine (l2-l4) are eligible
Beschrijving

Bone Mineral Density Test Lumbar spine T score

Datatype

boolean

Alias
UMLS CUI [1,1]
C0177804
UMLS CUI [1,2]
C3887615
UMLS CUI [1,3]
C3854607
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with normal bmd at trial entry
Beschrijving

Bone Mineral Density Normal

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005938
UMLS CUI [1,2]
C0205307
patients who received any prior bisphosphonate therapy in the past 12 months
Beschrijving

Diphosphonates

Datatype

boolean

Alias
UMLS CUI [1]
C0012544
treatment with anti-androgen mono- or combination therapy
Beschrijving

Antiandrogen therapy | Antiandrogen therapy Combined

Datatype

boolean

Alias
UMLS CUI [1]
C0279492
UMLS CUI [2,1]
C0279492
UMLS CUI [2,2]
C0009429
patients who are currently receiving diethylstilbesterol (des) or who have previously received pc-spes
Beschrijving

Diethylstilbestrol | PC-SPES

Datatype

boolean

Alias
UMLS CUI [1]
C0012203
UMLS CUI [2]
C0756934
patients who have received prior treatment with systemic corticosteroids within the past 12 months
Beschrijving

CORTICOSTEROIDS FOR SYSTEMIC USE

Datatype

boolean

Alias
UMLS CUI [1]
C3653708
patients with prior exposure to anabolic steroids or growth hormone within the past 6 months
Beschrijving

Anabolic steroids Exposure to | Growth Hormone Exposure to

Datatype

boolean

Alias
UMLS CUI [1,1]
C0002845
UMLS CUI [1,2]
C0332157
UMLS CUI [2,1]
C0037663
UMLS CUI [2,2]
C0332157
patients with any prior treatment for osteoporosis
Beschrijving

Therapeutic procedure Osteoporosis

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0029456
other protocol-defined inclusion/exclusion criteria may apply.
Beschrijving

Clinical Trial Eligibility Criteria Study Protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Terug naar het begin van de pagina

Similar models

Eligibility Prostate Cancer NCT00391950

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma
Item
histologically confirmed diagnosis of carcinoma of the prostate
boolean
C0600139 (UMLS CUI [1])
Distant metastasis Absent
Item
no distant metastases
boolean
C1269798 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Indication Antiandrogen therapy
Item
patients must be candidates for androgen deprivation therapy (adt)
boolean
C3146298 (UMLS CUI [1,1])
C0279492 (UMLS CUI [1,2])
Bone Mineral Density Test Lumbar spine T score
Item
patient with a baseline bmd t-score at or below -1 standard deviations in the lumbar spine (l2-l4) are eligible
boolean
C0177804 (UMLS CUI [1,1])
C3887615 (UMLS CUI [1,2])
C3854607 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Bone Mineral Density Normal
Item
patients with normal bmd at trial entry
boolean
C0005938 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
Diphosphonates
Item
patients who received any prior bisphosphonate therapy in the past 12 months
boolean
C0012544 (UMLS CUI [1])
Antiandrogen therapy | Antiandrogen therapy Combined
Item
treatment with anti-androgen mono- or combination therapy
boolean
C0279492 (UMLS CUI [1])
C0279492 (UMLS CUI [2,1])
C0009429 (UMLS CUI [2,2])
Diethylstilbestrol | PC-SPES
Item
patients who are currently receiving diethylstilbesterol (des) or who have previously received pc-spes
boolean
C0012203 (UMLS CUI [1])
C0756934 (UMLS CUI [2])
CORTICOSTEROIDS FOR SYSTEMIC USE
Item
patients who have received prior treatment with systemic corticosteroids within the past 12 months
boolean
C3653708 (UMLS CUI [1])
Anabolic steroids Exposure to | Growth Hormone Exposure to
Item
patients with prior exposure to anabolic steroids or growth hormone within the past 6 months
boolean
C0002845 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
C0037663 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
Therapeutic procedure Osteoporosis
Item
patients with any prior treatment for osteoporosis
boolean
C0087111 (UMLS CUI [1,1])
C0029456 (UMLS CUI [1,2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial